Gary S. Hogge - Feb 11, 2022 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
SVP,Clinical & Medical Affairs
Signature
/s/ Grant Harbert, as Attorney-in Fact
Stock symbol
LCTX
Transactions as of
Feb 11, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2022, 06:42 PM
Previous filing
Dec 30, 2021
Next filing
Mar 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Restricted Stock Units Award $0 +52.1K $0.00 52.1K Feb 11, 2022 Common Shares 52.1K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.
F2 Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.